Collaboration of Hprt/K-RAS/c-Myc mutation in the oncogenesis of T-lymphocytic leukemia: a comparative study

References

• Wang H, Naghavi M, Allen C et al. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet 388, 1459–1544 (2016).
   PubMed Web of Science ®Google Scholar
• Vardiman JW, Thiele J, Arber DA et al. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood 114, 937–951 (2009).
   PubMed Web of Science ®Google Scholar
• Wang T, Zang W, Ma Y et al. DNA polymerase beta promoter mutations affect gene transcription, translation and the sensitivity of esophageal cancer cells to cisplatin treatment. Mol. Biol. Reports 40, 1333–1339 (2013).
   PubMed Web of Science ®Google Scholar
• Shapira T, Pereg D, Lishner M. How I treat acute and chronic leukemia in pregnancy. Bl. Rev. 22, 247–259 (2008).
   PubMed Web of Science ®Google Scholar
• Lin YW, Perkins JJ, Zhang Z, Aplan PD. Distinct mechanisms lead to HPRT gene mutations in leukemic cells. Genes, Chromos. Can. 39, 311–323 (2004).
   PubMed Web of Science ®Google Scholar
• Langenau DM, Traver D, Ferrando AA et al. Myc-induced T cell leukemia in transgenic zebrafish. Sci. 299, 887–890 (2003).
   PubMed Web of Science ®Google Scholar
• Wu J, Wang S, Liang L et al. Investigation on the competition of duplex/G-quadruplex/i-motif in telomere sequences and c-MYC gene with a solid-state nanopore sensor. Sens. Actuators B: Chem. 348, 130712 (2021).
   Web of Science ®Google Scholar
• Chiang MY, Xu L, Shestova O et al. Leukemia-associated NOTCH1 alleles are weak tumor initiators but accelerate K-ras-initiated leukemia. J. Clin. Invest. 118, 3181–3194 (2008).
   PubMed Web of Science ®Google Scholar
• Mizuno T, Yamasaki N, Miyazaki K et al. Overexpression/enhanced kinase activity of BCR/ABL and altered expression of Notch1 induced acute leukemia in p210BCR/ABL transgenic mice. Oncog. 27, 3465–3474 (2008).
   PubMed Web of Science ®Google Scholar
• Palomero T, Barnes K, Real P et al. CUTLL1, a novel human T-cell lymphoma cell line with t (7; 9) rearrangement, aberrant NOTCH1 activation and high sensitivity to γ-secretase inhibitors. Leuk 20, 1279–1287 (2006).
   PubMed Web of Science ®Google Scholar
• Doytchinova I. Drug Design-Past, Present, Future. Molecules 27(5), 1496 (2022).
   PubMed Web of Science ®Google Scholar
• Gibson JM, Alzghari S, Ahn C, Trantham H, La-Beck NM. The role of pegylated liposomal doxorubicin in ovarian cancer: a meta-analysis of randomized clinical trials. Oncologist 18(9), 1022–31 (2013).
   PubMed Web of Science ®Google Scholar
• Tacar O, Sriamornsak P, Dass CR. Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems. J. Pharm. Pharmacol. 65, 157–170 (2013).
   PubMed Web of Science ®Google Scholar
• Brown RK. The effects of thymoquinone and Doxorubicin on leukemia and cardiomyocyte cell lines. University of Mississippi Medic. Cent. 50, 391–396 (2014).
   Google Scholar
• Kumar S, Tchounwou PB. Molecular mechanisms of cisplatin cytotoxicity in acute promyelocytic leukemia cells. Oncotarget 6, 40734 (2015).
   PubMedGoogle Scholar
• Mody MD, Gill HS, Higgins KA et al. Complete remission of acute myeloid leukemia following cisplatin based concurrent therapy with radiation for squamous cell laryngeal cancer. Case Reports in Hematol. 2016, 8581421 (2016).
   PubMedGoogle Scholar
• Iliopoulos D, Hirsch HA, Struhl K. Metformin decreases the dose of chemotherapy for prolonging tumor remission in mouse xenografts involving multiple cancer cell types. Canc. Res. 71, 3196–3201 (2011).
   PubMed Web of Science ®Google Scholar
• Bei D, Marszalek J, Youan B-BC. Formulation of dacarbazine-loaded cubosomes-part I: influence of formulation variables. Aaps Pharm. Scitech. 10, 1032–1039 (2009).
   PubMed Web of Science ®Google Scholar
• Saber MM, Al-Mahallawi AM, Stork B. Metformin dampens cisplatin cytotoxicity on leukemia cells after incorporation into cubosomal nanoformulation. Biomed. Pharmacother. 143, 112140 (2021).
   PubMed Web of Science ®Google Scholar
• Todorova VK, Kaufmann Y, Luo S, Klimberg VS. Modulation of p53 and c-myc in DMBA-induced mammary tumors by oral glutamine. Nutrit. Cancer 54, 263–273 (2006).
   PubMed Web of Science ®Google Scholar
• Wang H, Huang Y. Combination therapy based on nano codelivery for overcoming cancer drug resistance. Med. Drug Disc. 6, 100024 (2020).
   Google Scholar
• Mader JS, Salsman J, Conrad DM, Hoskin DW. Bovine lactoferricin selectively induces apoptosis in human leukemia and carcinoma cell lines. Mol. Cancer Therap. 4, 612–624 (2005).
   PubMed Web of Science ®Google Scholar
• Van Gelder M, Van Oers M, Alemayehu WG et al. Efficacy of cisplatin-based immunochemotherapy plus alloSCT in high-risk chronic lymphocytic leukemia: final results of a prospective multicenter phase 2 HOVON study. Bone Marrow Transplant. 51, 799–806 (2016).
   PubMed Web of Science ®Google Scholar
• Ellefson DD, Dizerega GS, Espinoza T et al. Synergistic effects of co-administration of angiotensin 1–7 and Neupogen on hematopoietic recovery in mice. Cancer Chemother. Pharmacol. 53, 15–24 (2004).
   PubMed Web of Science ®Google Scholar
• Kadry MO, Megeed RMA. Ubiquitous toxicity of Mercuric Chloride in target tissues and organs: impact of Ubidecarenone and liposomal-Ubidecarenone STAT 5A/PTEN/PI3K/AKT signaling pathways. J. Trace Elem. Med. Biol. 74, 127058 (2022).
   PubMed Web of Science ®Google Scholar
• Kadry MO. Liposomal glutathione as a promising candidate for immunological rheumatoid arthritis therapy. Heliy 5(7), e02162 (2019).
   PubMed Web of Science ®Google Scholar
• Jung P, Hermeking H. The c-MYC-AP4-p21 cascade. Cell Cycle 8(7), 982–989 (2009).
   PubMed Web of Science ®Google Scholar
• Dong J, Naito M, Tsuruo T. c-Myc plays a role in cellular susceptibility to death receptor-mediated and chemotherapy-induced apoptosis in human monocytic leukemia U937 cells. Oncog. 15, 639–647 (1997).
   PubMed Web of Science ®Google Scholar
• Finette BA, Poseno T, Albertini RJ. V(D)J recombinase-mediated HPRT mutations in peripheral blood lymphocytes of normal children. Cancer Res. 56, 1405–1412 (1996).
   PubMed Web of Science ®Google Scholar
• Aminuddin A, Ng PY, Leong C-O, Chua EW. Mitochondrial DNA alterations may influence the cisplatin responsiveness of oral squamous cell carcinoma. Scientific Reports. 10, 7885 (2020).
   PubMed Web of Science ®Google Scholar
• Tomita-Mitchell A, Ling LL, Glover CL et al. The mutational spectrum of the HPRT gene from human T cells in vivo shares a significant concordant set of hot spots with MNNG-treated human cells. Cancer Res. 63, 5793–5798 (2003).
   PubMed Web of Science ®Google Scholar
• Caiola E, Salles D, Frapolli R et al. Base excision repair-mediated resistance to cisplatin in KRAS (G12C) mutant NSCLC cells. Oncotarg. 6, 30072 (2015).
   PubMedGoogle Scholar
• Kowshik J, Baba AB, Giri H et al. Astaxanthin inhibits JAK/STAT-3 signaling to abrogate cell proliferation, invasion and angiogenesis in a hamster model of oral cancer. PLOS ONE 9, e109114 (2014).
   PubMed Web of Science ®Google Scholar
• Wu W, Xue X, Chen Y et al. Targeting prolyl isomerase Pin1 as a promising strategy to overcome resistance to cancer therapies. Pharmacol. Res. 184, 106456 (2022).
   PubMed Web of Science ®Google Scholar
• Kadry MO, Abdel-Megeed RM. Titanium-nanostructured and PEGylated Doxorubicin diminish chemotherapeutic resistance in 3-methylcholanthrene renal epithelial cell carcinoma via KRAS/FKBP5/P53/JAK2 signaling. Gene Express 22(3), 183–191 (2023).
   Google Scholar
• Abdel-Megeed RM, Abd El-Alim SH, Arafa AF et al. Crosslink among phosphatidylinositol-3 kinase/Akt, PTEN and STAT-5A signaling pathways post liposomal galactomannan hepatocellular carcinoma therapy. Toxicol. Rep. 7, 1531–1541 (2020).
   PubMed Web of Science ®Google Scholar
• Ali SA, Arafa AF, Aly HF et al. DNA damage and genetic aberration induced via different sized silver nanoparticles: therapeutic approaches of casimiroa edulis and glycosmis pentaphylla leaves extracts. J. Food Biochem. 4, e13398 (2020).
   Google Scholar
• Rizk MZ, Ali SA, Kadry MO et al. C-reactive protein signaling and chromosomal abnormalities in nanotoxicity induced via different doses of TiO2 (80 nm) boost liver function. Biol. Trace Elem. Res. 198(1), 157–167 (2020).
   PubMed Web of Science ®Google Scholar
• Abdel-Megeed RM, El Newary SA, Kadry MO et al. Hyssopus officinalis exerts hypoglycemic effects on streptozotocin-induced diabetic rats via modulating GSK-3β, C-fos, NF-κB, ABCA1 and ABGA1 gene expression. J. Diabetes Metab. Disord. 19(1), 483–491 (2020).
   PubMed Web of Science ®Google Scholar
• Hassan SA, Rizk MZ, El Sharkawi FZ, Badary OA, Kadry MO. The possible synergestic role of phytic acid and catechin in ameliorating the deteriorative biochemical effects induced by carbon tetrachloride in rats. J. Appl. Sci. Res. 3, 1449–1459 (2007).
   Google Scholar